Blog
    Peptide SpotlightFor PatientsSeptember 20, 2026

    Are All Peptides Proven to Work? Let’s Check the Facts

    Is every peptide therapy backed by science? We look at the evidence grades for semaglutide, tirzepatide, and others to see what is actually proven.

    You might have heard that all peptides are some kind of magic fix that just works for everyone. It sounds great, but the reality is a bit more like a report card. Some peptides are the straight-A students with high honors, while others are still sitting in the back of the classroom waiting for their test results.

    The overachievers

    Some compounds really have done their homework. Semaglutide and Tirzepatide both carry a Grade: A+ because they have gone through massive clinical trials.

    • Semaglutide showed a 14.9% weight loss in the STEP 1 trial and a 20% reduction in major heart events in the SELECT study.
    • Tirzepatide performed even better in the SURMOUNT-1 trial, reaching 22.5% weight loss.

    These are FDA-approved, which means the government agrees the evidence is there. However, they aren't perfect. Semaglutide, for instance, has a strong signal for side effects like nausea and vomiting, and studies show people often regain weight after stopping.

    The specialists and the travelers

    Then you have peptides that work, but only for very specific things. Tesamorelin has a Grade: A, but it is only FDA-approved for HIV-associated lipodystrophy (a specific way the body distributes fat). If you stop using it, the effects completely reverse. Scientists are still waiting for more evidence on using it for general fat loss.

    Thymosin Alpha-1 has a Grade: A- and is approved in over 35 countries, but not in the US. It has helped over 1,000 patients in hepatitis trials, but using it for things like anti-aging is still a bit of a question mark because the best dose hasn't been figured out yet.

    The ones still waiting for a grade

    Some substances get lumped in with peptides even when they technically aren't one. MK-677 is actually a small-molecule ghrelin mimetic (it copies a hunger hormone). It has a Grade: B. While it can help restore growth hormone levels, it failed in an Alzheimer's trial and can actually worsen insulin sensitivity.

    Similarly, Semax has a Grade: B. It has been used in Russia for stroke treatment since the 1990s, but there is very little validation from Western clinical trials.

    What should you do with this info?

    It turns out the human body is complicated. Who knew? Just because you see a peptide mentioned online doesn't mean it has the same level of proof as a doctor-prescribed medication.

    This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory. If you are looking for a peptide therapy clinic to discuss these evidence grades, make sure they are looking at the same data you are.

    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    Referenced Peptides

    semaglutidetirzepatidetesamorelinthymosin alpha 1mk 677semax

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.